Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Amidon G. L. et al., Estimating human oral fraction dose absorbed: a correlation using rat instestinal membrane permeability for passive and carrier-mediated compounds, Pharm. Res. 5: 651–654, 1988.CrossRefPubMedGoogle Scholar
  2. Artursson P., Cell culture as models for drug absorption across the intestinal mucosa, Crit. Rev. Ther. Drug Carrier Syst. 8: 305–330, 1991.PubMedGoogle Scholar
  3. Artursson P. and Karlsson J., Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells, Biochem. Biophys. Res. Comm. 175: 880–885, 1991.CrossRefPubMedGoogle Scholar
  4. Baijal P. K. and Fitzpatrick D. W., Effect of dietary protein on hepatic and extrahepatic phase I and phase II drug metabolizing enzymes, Toxicol. Lett. 89: 99–106, 1996.CrossRefPubMedGoogle Scholar
  5. Cassidy M. K. and Houston J. B., In vivo assessment of extrahepatic conjugative metabolism in first pass effects using the model compound phenol, J. Pharm. Pharmacol. 32: 57–59, 1980.PubMedGoogle Scholar
  6. Cutler D., Assessment of rate and extent of drug absorption, Pharmacol. Ther. 14: 123–160, 1991.Google Scholar
  7. Dressman J. B., Comparsion of canine and human gastrointestinal physiology, Pharm. Res. 3: 123–131, 1986.CrossRefGoogle Scholar
  8. Dressman J. B. et al., Gastrointestinal parameters that influences oral medications, J. Pharm. Sci. 82: 857–872, 1993.PubMedGoogle Scholar
  9. Fujieda Y. et al., Local absorption kinetics of levofloxacin from intestinal tract into portal vein in conscious rat using portal-venous concentration difference, Pharm. Res. 13: 1201–1204, 1996.CrossRefPubMedGoogle Scholar
  10. Gatmaitan Z. C. and Arias I. M., Structure and function of P-glycoprotein in normal liver and small intestine, Adv. Pharmacol. 24 77–97, 1993.PubMedGoogle Scholar
  11. Hansch C. and Leo A., Substituent Constants for Correlation Analysis in Chemistry and Biology, Wiley (Interscience), New York, 1979.Google Scholar
  12. Hidalgo I. J. et al., Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability, Gastroenterology 96: 736–749, 1989.PubMedGoogle Scholar
  13. Hidalgo I. J., Cultured intestinal epithelial cell models, in R. T. Borchardt, P. L. Smith and G. Wilson (eds.), Models for Assessing Drug Absorption and Metabolism, Plenum Press, New York, 1996, p. 39.Google Scholar
  14. Hillgren K. M. et al., In vitro systems for studying intestinal drug absorption, Med. Res. Rev.., 15: 83–109, 1995.PubMedGoogle Scholar
  15. Hirom P. C. et al., The physicochemical factor required for the biliary excretion of organic cations in the bile of the rat, rabbit and guinea pig, Biochem. Soc. Trans. 3: 327–330, 1974.Google Scholar
  16. HÖrter D. and Dressman J. B., Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract, Adv. Drug Del. Rev.. 25: 3–14, 1997.Google Scholar
  17. Hunt S. M. and Groff J. L., The digestive system: mechanisms for nourishing the body, in S. M. Hunt and J. L. Groff (eds.), Advanced Nutritional and Human Metabolism, West, New York, 1990, p. 39.Google Scholar
  18. Hunter J. and Hirst B. H., Intestinal secretion of drug: the role of P-glycoprotein and related drug efflux systems in limiting oral drug absorption, Adv. Drug Del. Rev. 25: 129–157, 1997.Google Scholar
  19. Kararli T. T., Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals, Biopharm. Drug Dispos. 16: 351–380, 1995.PubMedGoogle Scholar
  20. Kim D. et al., A correlation between the permeability characteristics of a series of peptides using an in vitro cell culture model (Caco-2) and those using an in situ perfused rat ileum model of the intestinal mucosa, Pharm. Res. 10: 1710–1714, 1993.CrossRefPubMedGoogle Scholar
  21. Krarup L. H., Predicting drug absorption from molecular surface properties based on molecular dynamics simulations, Pharm. Res. 15: 972–978, 1998.CrossRefPubMedGoogle Scholar
  22. Kwan K. C., Oral bioavailability and first-pass effects, Drug Metab. Dispos. 25: 1329–136, 1998.Google Scholar
  23. Kwon Y., Theoretical considerations on two equations for estimating the extent of absorption after oral administration of drugs, Pharm. Res. 13: 566–569, 1996.CrossRefPubMedGoogle Scholar
  24. Lee C.-P. et al., Selection of drug development candidates based on in vitro permeability measurements, Adv. Drug Del. Rev. 23: 47–62, 1997.Google Scholar
  25. Leveque D. and Jehl F., P-glycoprotein and pharmacokinetics, Anticancer Res. 15: 331–336, 1995.PubMedGoogle Scholar
  26. Lipinski C. A. et al., Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Adv. Drug Del. Rev. 23: 3–25, 1997.Google Scholar
  27. Moriguchi I. et al., Simple method of calculating octanol/water partition coefficient, Chem. Pharm. Bull. 40: 127–130, 1992.Google Scholar
  28. Mummaneni V. et al., Gastric pH influences the appearance of double peaks in the plasma concentration-time profiles of cimetidine after oral administration in dogs, Pharm. Res.12: 780–786, 1995.Google Scholar
  29. Muranishi S., Drug targeting towards the lymphatics, Adv. Drug Res. 21: 1–37, 1991.Google Scholar
  30. Palm K. et al., Correlation of drug absorption with molecular surface properties, J. Pharm. Sci. 85:32–39, 1996.CrossRefPubMedGoogle Scholar
  31. Pang K. S., Metabolic first-pass effects, J. Clin. Pharmacol. 26: 580–582, 1986.PubMedGoogle Scholar
  32. Raoof A. A. et al., Assessment of regional differences in intestinal fluid movement in the rat using a modified in situ single pass perfusion model, Pharm. Res. 15: 1314–1316, 1998.CrossRefPubMedGoogle Scholar
  33. Reppas C. et al., Effect of elevated viscosity in the upper gastrointestinal tract on drug absorption in dogs, Eur. J. Pharm. Sci. 6: 131–139, 1998.PubMedCrossRefGoogle Scholar
  34. Rubas W. et al., Comparison of the permeability characteristics of a human colonic epithelial (Caco-2) cell line to colon of rabbit, monkey, and dog intestineand humandrug absorption, Pharm. Res. 10: 113–118, 1993.CrossRefPubMedGoogle Scholar
  35. Smith D. A. et al., Design of toxicokinetic studies, Xenobiotica 20: 1185–1199, 1990.Google Scholar
  36. Tabata K. et al., Evaluation of intestinal absorption into the portal system in enterohepatic circulation by measuring the difference inportal-venous blood concentrations ofdiclofenac, Pharm. Res. 12: 880–883, 1995.CrossRefPubMedGoogle Scholar
  37. Tanigawara Y. et al., Moment analysis for the separation of mean in vivo disintegration, dissolution, absorption and disposition time of ampicillin products, J. Pharm. Sci., 71: 1129–1133, 1982.PubMedGoogle Scholar
  38. Testa B. et al., Lipophilicity in molecular modeling, Pharm. Res. 14: 1332–1340, 1997.CrossRefGoogle Scholar
  39. Tsuji A. and Tamai I., Carrier-mediated intestinal transport of drugs, Pharm. Res. 13: 963–977, 1996.CrossRefPubMedGoogle Scholar
  40. Wacher V. J. et al., Active secretion and enterocytic drug metabolism barriers to drug absorption, Adv. Drug Del. Rev. 20: 99–112, 1996.CrossRefGoogle Scholar
  41. Walter-Sack I., What is “fasting” drug administration? On the role of gastric motility in drug absorption, Eur. J. Clin. Pharmacol. 42: 11–13, 1992.PubMedGoogle Scholar
  42. Winne D., Influence of blood flow on intestinal absorption of xenobiotics, Pharmacology, 21: 1–15, 1980.PubMedCrossRefGoogle Scholar
  43. Zhang L. et al., Role of organic cation transporters in drug absorption and elimination, Annu. Rev., Pharmacol. Toxicol. 38: 431–460, 1998.CrossRefGoogle Scholar
  44. Zhi J. et al., Effects of dietary fat on drug absorption, Clin. Pharmacol. Ther., 58: 487–491, 1995.CrossRefPubMedGoogle Scholar
  45. Zimmerman C. L. et al., Evaluation of gastrointestinal absorption and metabolism, Drug Metab. Rev. 29: 957–975, 1997.PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 2002

Personalised recommendations